Protocol Memory Deficit in Patients With Obstructive Sleep Apnea Syndrome
Comparison of the Evolution of Memory Deficit in Patients With Sleep Apnea Obstructive Syndrome (SAOS) Before and After "Effective" Versus Sham Treatment by Positive Pression Continues (PPC)
1 other identifier
interventional
40
1 country
1
Brief Summary
The main objective of this study is to evaluate the evolution of memory deficit (verbal episodic memory, procedural memory, working memory, short-term memory) in Sleep Apnea Obstructive Syndrome (SAOS) patients after treatment by Continuous Positive Airway Pressure treatment (CPAP). For thus, we will compare memory tests in two separate groups of SAOS patients with "effective " versus "ineffective" ( or sham) CPAP, before and 6 weeks after the beginning of the treatment. Thus we will assess the evolution of memory deficit, the effectiveness of the treatment on the evolution of memory deficit before and 6 weeks after the beginning of the treatment by "effective " versus "ineffective" CPAP. We feel the results of the tests of memory will show greater memory disorders in patients with SAOS before beginning the treatment rather than six weeks afterwards. Thus we hypothesise that, after the treatment by "effective" CPAP, the patients with SAOS will have greater improvement of their memory disorders than those treated by "sham CPAP".
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2007
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
April 20, 2007
CompletedFirst Posted
Study publicly available on registry
April 23, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedDecember 30, 2015
December 1, 2015
6.2 years
April 20, 2007
December 29, 2015
Conditions
Keywords
Study Arms (2)
Effective CPAP treatment
EXPERIMENTALEffective Continuous Positive Airway Pressure treatment (CPAP) applied for 6 weeks
Sham CPAP treatment
SHAM COMPARATORIneffective Continuous Positive Airway Pressure treatment (sham CPAP) applied for 6 weeks
Interventions
Auto-titrating CPAP machines (Remstar Auto; Philips Respironics, Murrysville, PA) provided by a home care company (Bastide Medical, France). Pressure was set between 6 and 14 cm of water
Similar CPAP machine delivering a 4 cm of water pressure that was too low to suppress sleep respiratory events.
Eligibility Criteria
You may qualify if:
- Major patients,
- agreeing,
- diagnosed suffering from the SAOS,
- regulation by the specialist in a treatment by CPAP,
- patients do not begin the treatment
- affiliated to the social security,
- fluent in French.
You may not qualify if:
- Patients presenting severe depressive disorders (HADS score\>19),
- intellectual deterioration (MMS\< 28),
- a functional failure of the dominant arm upper limb inhibiting realization of graphic tasks,
- an associated oxygen treatment,
- suffering from cancer,
- cerebro-vascular accident,
- pregnant or nursing women,
- adult under supervision or trusteeship,
- antidepressant and anxiolytic treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Laboratoire EFCR-Functional Cardio-Respiratory Exploration Laboratory
Grenoble, Isere, France
Related Publications (6)
Beebe DW, Gozal D. Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits. J Sleep Res. 2002 Mar;11(1):1-16. doi: 10.1046/j.1365-2869.2002.00289.x.
PMID: 11869421BACKGROUNDEngleman HM, Douglas NJ. Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome. Thorax. 2004 Jul;59(7):618-22. doi: 10.1136/thx.2003.015867.
PMID: 15223874BACKGROUNDFarre R, Hernandez L, Montserrat JM, Rotger M, Ballester E, Navajas D. Sham continuous positive airway pressure for placebo-controlled studies in sleep apnoea. Lancet. 1999 Apr 3;353(9159):1154. doi: 10.1016/S0140-6736(99)01056-9. No abstract available.
PMID: 10209985BACKGROUNDNaegele B, Launois SH, Mazza S, Feuerstein C, Pepin JL, Levy P. Which memory processes are affected in patients with obstructive sleep apnea? An evaluation of 3 types of memory. Sleep. 2006 Apr;29(4):533-44. doi: 10.1093/sleep/29.4.533.
PMID: 16676787BACKGROUNDJoyeux-Faure M, Naegele B, Pepin JL, Tamisier R, Levy P, Launois SH. Continuous positive airway pressure treatment impact on memory processes in obstructive sleep apnea patients: a randomized sham-controlled trial. Sleep Med. 2016 Aug;24:44-50. doi: 10.1016/j.sleep.2016.06.023. Epub 2016 Aug 23.
PMID: 27810185DERIVEDJullian-Desayes I, Tamisier R, Zarski JP, Aron-Wisnewsky J, Launois-Rollinat SH, Trocme C, Levy P, Joyeux-Faure M, Pepin JL. Impact of effective versus sham continuous positive airway pressure on liver injury in obstructive sleep apnoea: Data from randomized trials. Respirology. 2016 Feb;21(2):378-85. doi: 10.1111/resp.12672. Epub 2015 Nov 16.
PMID: 26567858DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Louis JP Pépin, ProfessorPhD
University Hospital, Grenoble
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 20, 2007
First Posted
April 23, 2007
Study Start
April 1, 2007
Primary Completion
June 1, 2013
Study Completion
June 1, 2013
Last Updated
December 30, 2015
Record last verified: 2015-12
Data Sharing
- IPD Sharing
- Will share
All individual patient data are anonymized